How is the Rein Therapeutics Inc. today?

The Rein Therapeutics Inc. today is trading in the green, up by 4.66% at 2.02.

What is Rein Therapeutics Inc. Annual Net Profit?

Rein Therapeutics Inc. Annual Net Profit fell 299.71% in the last year to $62.88 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Rein Therapeutics Inc. Price to Earning Ratio?

Rein Therapeutics Inc. Price to Earning Ratio is -0.73, which is negative.

What is Rein Therapeutics Inc. Stock Price?

Rein Therapeutics Inc. Stock Price fell 36.88% and underperformed its sector by 63.42% in the past year.

What is Rein Therapeutics Inc. Quarterly Net profit?

Rein Therapeutics Inc. Quarterly Net profit rose 22.66% YoY to $5.5 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Rein Therapeutics Inc. Debt to Equity Ratio?

Rein Therapeutics Inc. Debt to Equity Ratio is zero as the company is debt-free.

What is Rein Therapeutics Inc. Return on Equity(ROE)?

Rein Therapeutics Inc. Return on Equity(ROE) for the last financial year was -772.8%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Rein Therapeutics Inc. Mutual Fund Holding?

Rein Therapeutics Inc. Mutual Fund Holding increased by 0.36% in the last quarter to 5.97.

What is Rein Therapeutics Inc. Promoter Share Holding?

Rein Therapeutics Inc. Promoter Share Holding stayed the same in the most recent quarter at 1.95%.

What is Rein Therapeutics Inc. Institutional Holding?

Rein Therapeutics Inc. Institutional Holding increased by 1.4% in the last quarter to 27.11.

Rein Therapeutics Inc. XNAS: RNTX

Rein Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Rein Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Rein Therapeutics Inc.
Rating: 1.07166675
Author: Trendlyne DVM scores

about

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LT...

2.02 0.09 (4.66%)

54.09% Fall from 52W High

37,817 XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

4.2 / 100

Technically Neutral

38.7 / 100

No estimates available

Rein Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rein Therapeutics Inc. FAQ

How is Rein Therapeutics Inc. today?

Rein Therapeutics Inc. today is trading in the green, and is up by 4.66% at 2.02.

How has Rein Therapeutics Inc. performed historically?

Rein Therapeutics Inc. is currently trading up 4.66% on an intraday basis. In the past week the stock fell -1.46%. stock has been down -3.35% in the past quarter and fell -36.88% in the past year. You can view this in the overview section.